PSORIASIS CLINICAL TRIAL

Researchers are testing an oral investigational medication’s effectiveness, safety and tolerability in men and women with moderate to severe plaque psoriasis.

It is hoped that the IMPACT-PS study will provide researchers information that can be used to create new treatments that may help reduce plaque psoriasis symptoms.

You may qualify to participate in this study If you:

• Are 18 to 70 years of age,
• Have a history of moderate to severe plaque psoriasis covering 10 percent of body surface area for at least six months
• Have no other severe conditions such as eczema or acne

Additional requirements apply

The oral investigation medication and all study related tests will be provided at no cost.

For more information,

Please contact: (705) 503- 6331

or email: trials@simcoderm.com